About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Portland | 9,742 Studies Near You

Clinical TrialsPortland

Clinical Trials in Portland

Discover 9,742 clinical trials near Portland, Oregon. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-40 of 9,742 trials

Active not recruitingA Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)The goal of this study is to evaluate the efficacy and safety of pembrolizumab plus belzutifan plus lenvatinib or pembrolizumab/quavonlimab plus lenvatinib versus pembrolizumab…NCT04736706·Birmingham, Alabama and 261 others

Find Trials by Condition in Portland

Breast Cancerin Portland Lung Cancerin Portland Prostate Cancerin Portland Colorectal Cancerin Portland Melanomain Portland Leukemiain Portland Lymphomain Portland Pancreatic Cancerin Portland Ovarian Cancerin Portland Brain Cancerin Portland Diabetes

Data from ClinicalTrials.govTerms

CompletedDasatinib (BMS-354825) in Subjects With Myeloid Blast Phase Chronic Myeloid Leukemia Resistant to or Intolerant of Imatinib MesylateThe purpose of this study is to see what effect an investigational drug (BMS-354825) has on subjects who are currently in the myeloid blast phase of chronic myeloid leukemia (CML)…NCT00101816·Birmingham, Alabama and 61 others

CompletedStudy of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies and Small Cell Lung Cancer PatientsThe purpose of this study is to determine a well-tolerated dose of Carfilzomib in combination with Irinotecan (Phase 1b portion of the study) in subjects with relapsed small and…NCT01941316·Goodyear, Arizona and 7 others

CompletedFesoterodine Flexible Dose StudyThis Phase 3B study is designed to test if a fesoterodine flexible dose regimen is more effective than placebo in reducing micturition frequency and other overactive bladder (OAB)…NCT00536484·Mobile, Alabama and 94 others

Active not recruitingTesting the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean StudyThis phase II trial compares the usual treatment of radiation therapy alone to using the study drug, relugolix, plus the usual radiation therapy in patients with…NCT05053152·Phoenix, Arizona and 244 others

RecruitingPhase 2 Study to Assess the Safety and Efficacy of ANG003In this study, ANG003, a pancreatic enzyme replacement therapy (PERT; commonly called "enzymes"), is being investigated as a potential treatment for exocrine pancreatic…NCT07450547·Long Beach, California and 26 others

Active not recruitingCompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted TherapyThis trial studies how well paclitaxel, trastuzumab, and pertuzumab work in eliminating further chemotherapy after surgery in patients with HER2-positive stage II-IIIa breast…NCT04266249·Birmingham, Alabama and 1007 others

CompletedAO-176 in Multiple Solid Tumor MalignanciesThis is a first-in-human, Phase 1/2 multi-center, open-label, dose escalation and expansion study of AO-176 which will evaluate the safety, tolerability, pharmacokinetics (PK)…NCT03834948·Los Angeles, California and 9 others

WithdrawnSPEARHEAD 2 Study in Subjects With Recurrent or Metastatic Head and Neck CancerThis is a study to investigate the efficacy and safety of ADP-A2M4 in combination with pembrolizumab in HLA-A\*02 eligible and MAGE-A4 positive subjects with recurrent or…NCT04408898·Phoenix, Arizona and 7 others

CompletedCOHERE - COntextualized Care in cHcs' Electronic Health REcordsThis study was designed to develop and test clinical decision support (CDS) tools that present clinical care team members with a given patient's social risk information and…NCT05022316·San Francisco, California and 2 others

UnknownA Trial Comparing Bowel Preparation and Patient Tolerability of Miralax Versus GolytelyPrior to colonoscopies, the colon is cleansed using a laxative. Golytely is approved by the FDA for this purpose.NCT00889655·Portland, Oregon

RecruitingA Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative ColitisThe purpose of this protocol is to evaluate the efficacy (how well it works), safety and tolerability of oral icotrokinra as therapy in adult and adolescent participants with…NCT07196748·Chandler, Arizona and 401 others

CompletedA Study to Investigate the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) as an Adjunctive Therapy in Children and Adults With Lennox-Gastaut SyndromeThis is a two-part, multicenter, double-blind, parallel-group, placebo controlled study to evaluate the effect of ZX008 when used as adjunctive therapy for the treatment of…NCT03355209·Tucson, Arizona and 71 others

CompletedS0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone SurgeryRATIONALE: Everolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth or by blocking blood flow to the tumor.NCT01120249·Birmingham, Alabama and 1002 others

RecruitingPPMI Clinical - Establishing a Deeply Phenotyped PD CohortThe Parkinson Progression Marker Initiative (PPMI) is a longitudinal, observational, multi-center natural history study to assess progression of clinical features, digital…NCT04477785·Birmingham, Alabama and 49 others

CompletedStudy Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL)This is an open-label, randomized trial in relapsed refractory subjects with mantle cell lymphoma (MCL).NCT00117598·Little Rock, Arkansas and 72 others

CompletedStudy of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS)The purpose of this study is to determine whether ozanimod is effective in the treatment of relapsing multiple sclerosis (RMS).NCT02294058·Phoenix, Arizona and 223 others

CompletedPRESEPT Study: Evaluation of SEPT9 Biomarker Performance for Colorectal Cancer ScreeningThe purpose of this study is to collect blood specimens and clinical data from screening guideline eligible individuals designated by their physician to receive a screening…NCT00855348·Boca Raton, Florida and 22 others

CompletedEltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Subjects With Hepatitis C Related Liver DiseaseThe purpose of this study is to assess the ability of eltrombopag to maintain a platelet count sufficient to facilitate initiation of antiviral therapy, to minimise antiviral…NCT00516321·Birmingham, Alabama and 190 others

RecruitingQuantification & Classification of Inflammatory Cells in Uveitis Using OCTThe goal of this study is to determine if it's possible to use a high resolution imaging device called optical coherence tomography (OCT) to develop an unbiased, standard method…NCT07065747·Portland, Oregon

PreviousPage 2 of 488Next

in Portland

Heart Diseasein Portland